Salim Kanoun

Toulouse, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications

Standardized FDG-PET interpretation during CAR T-cell therapy in R/R DLBCL: a DESCAR-T study.

Standardized FDG-PET interpretation during CAR T-cell therapy in R/R DLBCL: a DESCAR-T study.

Journal: European journal of nuclear medicine and molecular imaging
Published: March 25, 2026

Large B-cell lymphoma: The LYSA pragmatic guidelines.

Large B-cell lymphoma: The LYSA pragmatic guidelines.

Journal: European journal of cancer (Oxford, England : 1990)
Published: October 21, 2025

Personalized baseline and residual TMTV influence treatment response and outcomes in relapsed/refractory lymphomas: results from the GATA study.

Personalized baseline and residual TMTV influence treatment response and outcomes in relapsed/refractory lymphomas: results from the GATA study.

Journal: European journal of nuclear medicine and molecular imaging
Published: December 18, 2024

Prognostic impact of metabolic tumor volume using the SUV4.0 segmentation threshold in 1,960 lymphoma patients from prospective LYSA trials.

Prognostic impact of metabolic tumor volume using the SUV4.0 segmentation threshold in 1,960 lymphoma patients from prospective LYSA trials.

Journal: European journal of nuclear medicine and molecular imaging
Published: December 12, 2024

Interim PET after 4 cycles predicts outcome in histomolecularly confirmed primary mediastinal B-cell lymphoma.

Interim PET after 4 cycles predicts outcome in histomolecularly confirmed primary mediastinal B-cell lymphoma.

Journal: Blood advances
Published: December 10, 2024

Classic Hodgkin Lymphoma: The LYSA pragmatic guidelines.

Classic Hodgkin Lymphoma: The LYSA pragmatic guidelines.

Journal: European journal of cancer (Oxford, England : 1990)
Published: July 25, 2024

Precautions to Consider in the Analysis of Prognostic and Predictive Indices.

Precautions to Consider in the Analysis of Prognostic and Predictive Indices.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: May 15, 2024

International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline 18F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation.

International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline 18F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: March 15, 2024

Positron emission tomography: a central role in assessment and evaluation

Positron emission tomography: a central role in assessment and evaluation

Journal: La Revue du praticien
Published: July 17, 2023

The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients.

The phase 2 LYSA study of prednisone, vinblastine, doxorubicin, and bendamustine for untreated Hodgkin lymphoma in older patients.

Journal: Blood
Published: June 20, 2023

Validation of the ΔSUVmax for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial.

Validation of the ΔSUVmax for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: April 14, 2023

Prognostic Value of 18F-FDG PET Radiomics Features at Baseline in PET-Guided Consolidation Strategy in Diffuse Large B-Cell Lymphoma: A Machine-Learning Analysis from the GAINED Study.

Prognostic Value of 18F-FDG PET Radiomics Features at Baseline in PET-Guided Consolidation Strategy in Diffuse Large B-Cell Lymphoma: A Machine-Learning Analysis from the GAINED Study.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: April 14, 2023
Showing 1-12 of 46

Last Updated: 09/26/2026